Q3 2023 Xenon Pharmaceuticals Inc Earnings Call Transcript
Hello. Thank you for standing by, and welcome to Xenon Pharmaceuticals Inc. Third Quarter 2023 Earnings Conference Call.
I would now like to turn the call over to Sherry Aulin, our CFO. You may now begin the conference.
Thank you. Good afternoon, everyone. Thank you for joining us on our call and webcast to discuss Xenon's third quarter 2023 financial and operating results. Joining me are Ian Mortimer, Xenon's President and Chief Executive Officer; Dr. Chris Kenney, Xenon's Chief Medical Officer; and Dr. Chris Von Seggern, Xenon's Chief Commercial Officer. Ian will open today's call with a summary of our progress. Chris Kenney will provide an overview of our ongoing XEN1101 clinical programs, and Chris Von Seggern will summarize key findings from our market research around the potential of 1101 in the major -- in major depressive disorder or MDD treatment landscape. I will summarize our financial results, progress within our partnered programs and anticipated company milestone events before opening the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |